Physician profile
Julia E Riley
NPI 1366541872
$933.92
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2020: $166 · 2021: $112 · 2022: $147 · 2023: $143 · 2024: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $284.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $264.30 | 2019-2024 | Bexsero, Pediarix, Rotarix |
| Pfizer INC. | $142.62 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $132.72 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $127.25 | 2024 | |
| Sanofi Pasteur INC. | $85.94 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $78.01 | 2019-2022 | |
| Ultragenyx Pharmaceutical INC. | $30.54 | 2019-2021 | |
| Nestle Healthcare Nutrition INC. | $17.74 | 2021 | |
| Adlon Therapeutics L.P. | $15.34 | 2020 | |
| Supernus Pharmaceuticals, INC. | $14.39 | 2023 | Qelbree |
| Mckesson Medical-Surgical, INC. | $13.85 | 2020 | |
| Mission Pharmacal Company | $11.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Riley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.